HRTS vs. CNCR

Last updated Jun 24, 2026

HRTS (Tema Obesity & Cardiometabolic ETF) and CNCR (Loncar Cancer Immunotherapy ETF) are both Health & Biotech Equities funds. HRTS is actively managed, while CNCR is passively managed. HRTS charges 0.75%/yr vs 0.79%/yr for CNCR.

Performance

HRTS vs. CNCR - Performance Comparison

The chart below illustrates the hypothetical performance of a $10,000 investment in Tema Obesity & Cardiometabolic ETF (HRTS) and Loncar Cancer Immunotherapy ETF (CNCR). The values are adjusted to include any dividend payments, if applicable.

Returns By Period

HRTS

• 1D: 1.50%
• 1M: 1.21%
• YTD: -1.45%
• 6M: -2.09%
• 1Y: 25.88%
• 3Y*: —
• 5Y*: —
• 10Y*: —

CNCR

• 1D: 0.00%
• 1M: 0.00%
• YTD: —
• 6M: —
• 1Y: —
• 3Y*: —
• 5Y*: —
• 10Y*: —

*Multi-year figures are annualized to reflect compound growth (CAGR)

HRTS vs. CNCR - Yearly Performance Comparison

	2026 (YTD)
HRTS Tema Obesity & Cardiometabolic ETF	-0.66%
CNCR Loncar Cancer Immunotherapy ETF	0.00%

HRTS vs. CNCR - Sectors Allocation Comparison

Sectors	HRTS	CNCR
Healthcare	100.0%	96.6%
Basic Materials	-	-
Communication Services	-	-
Consumer Cyclical	-	-
Consumer Defensive	-	-
Energy	-	-
Financial Services	-	3.3%
Industrials	-	-
Real Estate	-	-
Technology	-	-
Utilities	-	-

Return for Risk

HRTS vs. CNCR — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.

HRTS

HRTS Risk / Return Rank: 48
HRTS Sharpe Ratio Rank: 49
HRTS Sortino Ratio Rank: 54
HRTS Omega Ratio Rank: 46
HRTS Calmar Ratio Rank: 51
HRTS Martin Ratio Rank: 39

CNCR

Risk / return metrics aren't available yet — we need at least 12 months of trading data to calculate them.

The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

HRTS vs. CNCR - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for Tema Obesity & Cardiometabolic ETF (HRTS) and Loncar Cancer Immunotherapy ETF (CNCR). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.

	HRTS	CNCR	Difference
Sharpe ratio: Return per unit of total volatility	1.60	—	—
Sortino ratio: Return per unit of downside risk	2.42	—	—
Omega ratio: Gain probability vs. loss probability	1.27	—	—
Calmar ratio: Return relative to maximum drawdown	2.36	—	—
Martin ratio: Return relative to average drawdown	5.70	—	—

Drawdowns

HRTS vs. CNCR - Drawdown Comparison

The maximum HRTS drawdown since its inception was -25.81%, which is greater than CNCR's maximum drawdown of 0.00%. Use the drawdown chart below to compare losses from any high point for HRTS and CNCR.

Drawdown Indicators

	HRTS	CNCR	Difference
Max Drawdown Largest peak-to-trough decline	-25.81%	0.00%	-25.81%
Max Drawdown (1Y) Largest decline over 1 year	-11.01%	—	—
Current Drawdown Current decline from peak	-5.04%	0.00%	-5.04%
Average Drawdown Average peak-to-trough decline	-8.96%	0.00%	-8.96%
Ulcer Index Depth and duration of drawdowns from previous peaks	4.55%	—	—

Volatility

Volatility by Period

	HRTS	CNCR	Difference
Volatility (1M) Calculated over the trailing 1-month period	5.41%	—	—
Volatility (6M) Calculated over the trailing 6-month period	11.72%	—	—
Volatility (1Y) Calculated over the trailing 1-year period	16.22%	0.00%	+16.22%
Volatility (5Y) Calculated over the trailing 5-year period, annualized	19.08%	0.00%	+19.08%
Volatility (10Y) Calculated over the trailing 10-year period, annualized	19.08%	0.00%	+19.08%

HRTS vs. CNCR - Expense Ratio Comparison

HRTS has a 0.75% expense ratio, which is lower than CNCR's 0.79% expense ratio.

Dividends

HRTS vs. CNCR - Dividend Comparison

HRTS's dividend yield for the trailing twelve months is around 1.36%, while CNCR has not paid dividends to shareholders.

Position	TTM	2025	2024
CNCR Loncar Cancer Immunotherapy ETF	0.00%	0.00%	0.00%
HRTS Tema Obesity & Cardiometabolic ETF	1.36%	1.34%	1.63%

Frequently Asked Questions

Which ETF is better, HRTS or CNCR?

On fees, HRTS is cheaper at 0.75% per year. The better choice depends on whether you care most about return, fees, risk, or income.

Which ETF is cheaper, HRTS or CNCR?

HRTS is cheaper with a 0.75% expense ratio, compared with 0.79% for CNCR.

Which ETF pays a higher dividend yield, HRTS or CNCR?

HRTS has the higher dividend yield at 1.36%, compared with 0.00% for CNCR.

What is the main difference between HRTS and CNCR?

They also come from different issuers: Tema and Exchange Traded Concepts. Their fees differ too: 0.75% for HRTS and 0.79% for CNCR.